Vogenx (VOGX) sets $11–$13 IPO range targeting $75 million on Nasdaq
As seen on the 24/7 Wall St. homepage on July 29, 2026.
Biotech sets $11 to $13 pricing range on $75 million Nasdaq IPO
Vogenx amended its IPO registration to price 6.25 million shares between $11 and $13 apiece, targeting $75 million in proceeds for the Nasdaq listing.
Continue ReadingShow less
Vogenx, Inc. has amended its IPO registration with the SEC, setting a price range of $11 to $13 per share for 6.25 million shares. At the midpoint of that range, the offering would value the deal at around $75 million, which is also the stated proceeds target the company disclosed in the filing.
The amendment moves Vogenx into a more advanced stage of its Nasdaq listing process. An amended registration typically follows initial feedback from institutional investors during the roadshow, and the tightened price range signals the company is now closer to setting a final offering price. The proposed ticker is VOGX.
Sponsored
Are You Ready To Retire, Or Years Behind?
Most Americans suspect they're behind on retirement and never find out. Advisor.com's free matching tool pairs you in about three minutes with a vetted fiduciary advisor who can help you with investing, taxes, retirement, estate planning, and more. No minimums. No sales call. Find out where you stand.
Investors watching this deal will want to track when a final price is set and shares begin trading. As of the filing, no final price has been established.
Mentioned: VOGX